expenditure is of course influenced by policy and also by problems and inefficiencies on the market for pharmaceuticals production …

We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug … Launches database and the WHO Mortality Database. Under conservative assumptions, our estimates imply that the average annual … increase in life expectancy of the entire population resulting from new drug launches is about one week, and that the …

mortality rates using longitudinal, annual, cancer-site-level data based on records of 2.1 million people diagnosed with cancer … drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001" (http …

, pharmaceutical expenditures, and mortality rates. Reductions in pharmaceutical purchases and mortality are each valued at $900 …

neighbouring Afghanistan. Highlights the impact of radical Islamic groups, drug production and trade, migration and refugee …

the relationships between the frequency of marijuana use, negative consequences resulting from drug use, well-being, and … associated with well-being. However, negative consequences resulting from drug use were positively correlated with negative well … stimulants. The relationships between these drugs and well-being varied per individual drug. However, stimulants were …

This issue brief describes organizations offering the new Medicare drug benefit and analyzes how companies are …

Medicare HMOs, PPOs, and private fee-for-service plans) and new stand-alone prescription drug plans (PDPs). In 2006, all …